Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 08, 2021

SELL
$282.99 - $369.05 $4.01 Million - $5.23 Million
-14,172 Closed
0 $0
Q2 2021

Aug 05, 2021

SELL
$259.0 - $414.71 $336,959 - $539,537
-1,301 Reduced 8.41%
14,172 $4.91 Million
Q1 2021

May 07, 2021

SELL
$242.95 - $284.63 $433,665 - $508,064
-1,785 Reduced 10.34%
15,473 $4.33 Million
Q4 2020

Feb 09, 2021

SELL
$236.26 - $355.63 $576,474 - $867,737
-2,440 Reduced 12.39%
17,258 $4.23 Million
Q3 2020

Nov 09, 2020

BUY
$264.77 - $305.71 $1.54 Million - $1.77 Million
5,798 Added 41.71%
19,698 $5.59 Million
Q2 2020

Aug 14, 2020

SELL
$258.66 - $342.55 $28,452 - $37,680
-110 Reduced 0.79%
13,900 $3.72 Million
Q1 2020

May 11, 2020

BUY
$268.85 - $341.04 $233,092 - $295,681
867 Added 6.6%
14,010 $4.43 Million
Q4 2019

Feb 03, 2020

BUY
$220.06 - $304.07 $181,329 - $250,553
824 Added 6.69%
13,143 $3.9 Million
Q3 2019

Oct 29, 2019

SELL
$217.44 - $243.88 $217,222 - $243,636
-999 Reduced 7.5%
12,319 $2.87 Million
Q2 2019

Jul 18, 2019

SELL
$219.29 - $241.72 $33,989 - $37,466
-155 Reduced 1.15%
13,318 $3.12 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $108,788 - $170,157
502 Added 3.87%
13,473 $3.18 Million
Q4 2018

Feb 13, 2019

BUY
$278.5 - $352.75 $40,661 - $51,501
146 Added 1.14%
12,971 $3.9 Million
Q3 2018

Oct 15, 2018

SELL
$293.51 - $383.83 $372,757 - $487,464
-1,270 Reduced 9.01%
12,825 $4.53 Million
Q2 2018

Jul 30, 2018

BUY
$257.52 - $306.91 $495,468 - $590,494
1,924 Added 15.81%
14,095 $4.09 Million
Q1 2018

Apr 23, 2018

BUY
$260.13 - $367.91 $164,402 - $232,519
632 Added 5.48%
12,171 $3.33 Million
Q4 2017

Feb 15, 2018

BUY
$307.64 - $344.58 $3.55 Million - $3.98 Million
11,539
11,539 $3.68 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Main Street Investment Advisors LLC Portfolio

Follow Main Street Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Main Street Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Main Street Investment Advisors LLC with notifications on news.